ArticleThe Brown journal of hospital medicine2022
Acute Respiratory Distress Syndrome due to Influenza A Treated with Extracorporeal Membrane Oxygenation: A Case Report and Review of the Literature.
Article in The Brown journal of hospital medicine, 2022. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 1 paper.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
1 citing paper in PubMed.
- Bioavailability of a novel anti-influenza agent, onradivir granules, in healthy Chinese adults: a first-in-human study.Frontiers in pharmacology · 2026Trial
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
4 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Influenza is a viral respiratory infection that can lead to significant morbidity and mortality. Due to its high susceptibility to antigenic variation, influenza A is responsible for causing pandemics. Fever, cough, dyspnea, and vomiting are common presenting symptoms. The spectrum of an influenza A virus infection ranges from a mild upper respiratory illness to life-threatening pneumonia. Hypoxia and chest radiographs consistent with acute respiratory distress syndrome (ARDS) are seen in patients requiring intensive care. The reported incidence of patients with influenza A-associated ARDS requiring transition from conventional ventilation to extracorporeal membrane oxygenation (ECMO) is variable. ECMO can be considered in patients with reversible respiratory failure, who are already on maximal conventional therapy and are not achieving lung-protective ventilation; wherein the benefits of ECMO are deemed to outweigh its risks. We describe the case of a 48-year-old female who developed ARDS secondary to influenza A requiring mechanical ventilation and extracorporeal membrane oxygenation (ECMO).
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.